Coronary artery stenting in a patient with chronic immune thrombocytopenic purpura: a clinical conundrum
- 1School of Clinical Medicine, University of Cambridge, Cambridge, UK
- 2Gleneagles Medical Centre, Singapore, Singapore
- Correspondence to Charleen Min Li Chan Wah Hak,
A patient with long-standing immune thrombocytopenic purpura (ITP) would logically contradict antiplatelet use due to increased bleeding risk during coronary stenting. Coronary stenting using an endothelial progenitor cells (EPC) capture stents (GenousTM) was used to successfully revascularise our patient using a transradial approach. The only complication was extensive superficial ecchymosis on the patient's forearm from antiplatelet use, which resolved spontaneously. To the best of our knowledge, this is the first case report of EPC capture stents in a chronic ITP patient.